{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T20:22:32Z","timestamp":1700166152607},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1990,11,1]],"date-time":"1990-11-01T00:00:00Z","timestamp":657417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1990,11]]},"DOI":"10.1007\/bf02026489","type":"journal-article","created":{"date-parts":[[2005,8,10]],"date-time":"2005-08-10T13:52:28Z","timestamp":1123681948000},"page":"1443-1447","source":"Crossref","is-referenced-by-count":2,"title":["The role of serotonin in cardiovascular diseases and their treatment"],"prefix":"10.1007","volume":"4","author":[{"given":"P. A.","family":"van Zwieten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"Blauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"van Brummelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02026489_CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00005344-198406002-00017","volume":"6","author":"PM Vanhoutte","year":"1984","unstructured":"Vanhoutte PM, Cohen RA, van Nueten JM. Serotonin and arterial vessels.J Cardiovasc Pharmacol 1984;6:421\u2013428.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02026489_CR2","first-page":"123","volume-title":"Serotonin and the cardiovascular system","author":"PM Vanhoutte","year":"1985","unstructured":"Vanhoutte PM. Peripheral serotonergic receptors and hypertension. In: Vanhoutte PM, ed.Serotonin and the cardiovascular system. New York: Raven Press, 1985:123\u2013124."},{"issue":"Suppl 3","key":"BF02026489_CR3","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/00005344-198706103-00004","volume":"10","author":"PM Vanhoutte","year":"1987","unstructured":"Vanhoutte PM. Cardiovascular effects of serotonin.J Cardiovasc Pharmacol 1987; 10 (Suppl 3):S8-S11.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 3","key":"BF02026489_CR4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00005344-198706103-00003","volume":"10","author":"M G\u00f6thert","year":"1987","unstructured":"G\u00f6thert M, Schlicker E, Classification of serotonin receptors.J Cardiovasc Pharmacol 1987;10(Suppl 3) (Suppl 3):S3-S7.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02026489_CR5","first-page":"43","volume-title":"Serotonin and the cardiovascular system","author":"JE Leijsen","year":"1985","unstructured":"Leijsen JE. Serotonergic binding sites. In: Vanhoutte PM, ed.Serotonin and the cardiovascular system. New York, Raven Press, 1985:43\u201362."},{"key":"BF02026489_CR6","first-page":"3","volume":"7","author":"M G\u00f6thert","year":"1990","unstructured":"G\u00f6thert M. Pharmacological, biochemical and molecular classification schemes of serotonin (5HT)-receptors with special reference to the 5HT2-class.Prog Pharmacol 1990;7:3\u201316.","journal-title":"Prog Pharmacol"},{"key":"BF02026489_CR7","first-page":"27","volume-title":"Serotonin and the cardiovascular system","author":"CN Gillis","year":"1985","unstructured":"Gillis CN. Peripheral metabolism of serotonin. In: Vanhoutte PM, ed.Serotonin and the cardiovascular system. New York: Raven Press, 1985:27."},{"key":"BF02026489_CR8","first-page":"75","volume-title":"Serotonin in the cardiovascular system","author":"A Holmsen","year":"1985","unstructured":"Holmsen A. Platelet activation and serotonin. In: Vanhoutte PM, ed.Serotonin in the cardiovascular system. New York: Raven Press, 1985:75\u201386."},{"issue":"Suppl 1","key":"BF02026489_CR9","first-page":"S1","volume":"11","author":"F Clerck De","year":"1988","unstructured":"De Clerck F, Xhonneux R, Chafoy de Courcelles D. Functional expression of the amplification reaction between serotonin and epinephrine in platelets.J Cardiovasc Pharmacol 1988;11(Suppl 1):S1-S5.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02026489_CR10","first-page":"17","volume":"7","author":"PM Vanhoutte","year":"1990","unstructured":"Vanhoutte PM. Vascular effects of serotonin.Prog Pharmacol 1990;7:17\u201326.","journal-title":"Prog Pharmacol"},{"key":"BF02026489_CR11","unstructured":"Kalkman HO. Vascular Serotonin Receptors. Ph.D. Thesis, University of Amsterdam, 1983."},{"issue":"Suppl 3","key":"BF02026489_CR12","first-page":"143","volume":"2","author":"HO Kalkman","year":"1984","unstructured":"Kalkman HO, Engel G, Hoyer D. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.J Hypertens 1984;2(Suppl 3):143\u2013145.","journal-title":"J Hypertens"},{"key":"BF02026489_CR13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.HYP.11.3.256","volume":"11","author":"GJ Blauw","year":"1988","unstructured":"Blauw GJ, van Brummelen P, Chang PC, van Zwieten PA. Regional vascular effects of serotonin and ketanserin in young healthy subjects.Hypertension 1988;11:256\u2013263.","journal-title":"Hypertension"},{"issue":"Suppl 4","key":"BF02026489_CR14","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00004872-198812040-00006","volume":"6","author":"GJ Blauw","year":"1988","unstructured":"Blauw GJ, van Brummelen P, Chang PC, et al. 5HT3-receptor-mediated vasodilatation in the human forearm.J Hypertens 1988;6(Suppl 4):S33-S35.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"BF02026489_CR15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2165\/00003495-198800361-00012","volume":"36","author":"GJ Blauw","year":"1988","unstructured":"Blauw GJ, van Brummelen P, Chang PC, et al. Arterial dilatation and venous constriction induced by serotonin in the elderly.Drugs 1988;36(Suppl 1):74\u201377.","journal-title":"Drugs"},{"key":"BF02026489_CR16","first-page":"63","volume":"7","author":"PA Zwieten Van","year":"1990","unstructured":"Van Zwieten PA, Blauw GJ, van Brummelen P. Pathophysiological relevance of serotonin in cardiovascular diseases.Prog Pharmacol 1990;7:63\u201375.","journal-title":"Prog Pharmacol"},{"key":"BF02026489_CR17","unstructured":"Blauw GJ, van Brummelen P, Doorenbos CJ, van Zwieten PA. No evident vascular 5HT2-and \u03b11-adrenoceptor blockade during antihypertensive treatment with ketanserin. 13th Scientific Meeting of the International Society of Hypertension, Montr\u00e9al, June 1990."},{"key":"BF02026489_CR18","first-page":"218","volume":"42","author":"PPA Humphrey","year":"1983","unstructured":"Humphrey PPA, Feniuk W, Watts AD. Prejunctional effects of 5-hydroxytryptamine on noradrenergic nerves in the cardiovascular system.Fed Proc 1983;42:218\u2013222.","journal-title":"Fed Proc"},{"key":"BF02026489_CR19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00497016","volume":"324","author":"G Engel","year":"1983","unstructured":"Engel G, G\u00f6thert M, Mueller-Schweinitzer E, et al. Evidence for common pharmacological properties of [3H]-5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory 5-hydroxytryptamine receptors on sympathetic nerves.Naunyn-Schmiedeberg's Arch Pharmacol 1983;324:116\u2013124.","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02026489_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(82)90130-3","volume":"77","author":"JM Nueten Van","year":"1982","unstructured":"Van Nueten JM, Janssen PAJ, de Ridder W, Vanhoutte PM. Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit: Effect of ketanserin (R 41468).Eur J Pharmacol 1982;77:281\u2013287.","journal-title":"Eur J Pharmacol"},{"key":"BF02026489_CR21","first-page":"35","volume":"7","author":"JM Nueten Van","year":"1990","unstructured":"Van Nueten JM, Janssens WJ. Interactions between 5HT2-receptors and \u03b11-adrenoceptors in vascular tissues.Prog Pharmacol 1990:7:35\u201343.","journal-title":"Prog Pharmacol"},{"key":"BF02026489_CR22","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/0024-3205(74)90184-2","volume":"15","author":"L Finch","year":"1974","unstructured":"Finch L. Vascular reactivity in hypertensive rats after treatment with antihypertensive agents.Life Sci 1974;15:1827\u20131836.","journal-title":"Life Sci"},{"key":"BF02026489_CR23","doi-asserted-by":"crossref","unstructured":"Webb RC. Increased vascular sensitivity to serotonin and methysergide in hypertension in rats.Clin Sci 1982;63:72S.","DOI":"10.1042\/cs063073s"},{"key":"BF02026489_CR24","first-page":"233","volume":"42","author":"PM Vanhoutte","year":"1983","unstructured":"Vanhoutte PM. 5-Hydroxytryptamine and vascular disease.Fed Proc 1983;42:233\u2013237.","journal-title":"Fed Proc"},{"key":"BF02026489_CR25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(82)90469-X","volume":"2","author":"J Roose De","year":"1982","unstructured":"De Roose J, Symoens J. Ketanserin in acute superficial thrombophlebitis.Lancet 1982;2:440\u2013441.","journal-title":"Lancet"},{"key":"BF02026489_CR26","first-page":"424","volume":"1","author":"Prevention of atherosclerotic complications with Ketanserin Trial Group","year":"1989","unstructured":"Prevention of atherosclerotic complications with Ketanserin Trial Group. Prevention of atherosclerotic complications: Controlled trial of ketanserin.Lancet 1989;1:424\u2013430.","journal-title":"Lancet"},{"key":"BF02026489_CR27","first-page":"1069","volume":"285","author":"OK Roald","year":"1984","unstructured":"Roald OK, Seem E. Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.Br Med J 1984;285:1069\u20131071.","journal-title":"Br Med J"},{"key":"BF02026489_CR28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/000331978904000206","volume":"40","author":"O Codella","year":"1989","unstructured":"Codella O, Caramaschi P, Olivieri O, et al. Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.Angiology 1989;40:114\u2013118.","journal-title":"Angiology"},{"key":"BF02026489_CR29","unstructured":"Blauw GJ. 5-Hydroxytryptamine. Ph. D. Thesis, University of Amsterdam, 1989:99\u2013122."},{"key":"BF02026489_CR30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.64.6.1107","volume":"64","author":"M Tada","year":"1981","unstructured":"Tada M Kuzuya T, Inoue M, et al. Elevation of thromboxane B2-levels in patients with classic and variant angina pectoris.Circulation 1981;64:1107\u20131115.","journal-title":"Circulation"},{"key":"BF02026489_CR31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF01908043","volume":"77","author":"J Holtz","year":"1982","unstructured":"Holtz J, Held W, Sommer O, et al. Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: Alpha-adrenoceptors are not involved.Basic Res Cardiol 1982:77:278\u2013291.","journal-title":"Basic Res Cardiol"},{"issue":"Suppl 2","key":"BF02026489_CR32","first-page":"20","volume":"76","author":"W Klein","year":"1987","unstructured":"Klein W, Brandt D, Fluch N, Dusleag J. Prevention der Restenose durch Ketanserin.Zeitschr f Kardiologie 1987; 76(Suppl 2):20.","journal-title":"Zeitschr f Kardiologie"},{"key":"BF02026489_CR33","unstructured":"Noble NIM, Drake-Holland AJ. Prevention of coronary events in patients with critical coronary stenoses by serotonin antagonism.Prog Pharmacol 1990, in press"},{"key":"BF02026489_CR34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.77.3.678","volume":"77","author":"P Golino","year":"1988","unstructured":"Golino P, Ashton JH, Glas-Greenwalt A, et al. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.Circulation 1988;77:678\u2013684.","journal-title":"Circulation"},{"key":"BF02026489_CR35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1152\/physrev.1954.34.3.563","volume":"34","author":"IH Page","year":"1954","unstructured":"Page IH. Serotonin (5-hydroxytryptamine).Physiol Rev 1954;34:563\u2013588.","journal-title":"Physiol Rev"},{"issue":"Suppl. 1","key":"BF02026489_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003495-198800361-00010","volume":"36","author":"R Amstein","year":"1988","unstructured":"Amstein R, Fetkovska N, Ferracin F, et al. Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin.Drugs 1988;36(Suppl. 1):61\u201366.","journal-title":"Drugs"},{"key":"BF02026489_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00053439","volume":"4","author":"N Fetkovska","year":"1990","unstructured":"Fetkovska N, Pletscher A, Ferrazin F, et al. Impaired uptake of 5-hydroxytryptamine by platelets in essential hypertension: Clinical relevance.Cardiovasc Drugs Ther 1990; 4:105\u2013109.","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF02026489_CR38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00005344-198601000-00028","volume":"8","author":"K Jie","year":"1986","unstructured":"Jie K, van Brummelen P, Vermeij P, et al. \u03b11- and \u03b12-adrenoceptor-mediated vasoconstriction in the forearm of normotensive and hypertensive subjects.J Cardiovasc Pharmacol 1986;8:190\u2013196.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 5","key":"BF02026489_CR39","first-page":"S201","volume":"5","author":"GJ Blauw","year":"1987","unstructured":"Blauw GJ, van Brummelen P, Chang PC, et al. Vascular effects of serotonin and ketanserin in man.J Hypertens 1987;5(Suppl 5):S201-S203.","journal-title":"J Hypertens"},{"key":"BF02026489_CR40","first-page":"319","volume":"235","author":"ML Cohen","year":"1985","unstructured":"Cohen ML, Kurz KD, Mason MR, et al. Pharmacological activity of the isomers of LY 53857, a potent and selective 5HT2-receptor antagonist.J Pharmacol Exp Ther 1985; 235:319\u2013325.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02026489_CR41","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00005344-198311000-00006","volume":"5","author":"GA Head","year":"1983","unstructured":"Head GA, Korner PI, Lewis SL, Badoer E. Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and \u03b1-methyldopa in rabbits.J Cardiovasc Pharmacol 1983;5:945\u2013953.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02026489_CR42","first-page":"19","volume-title":"New drugs annual: cardiovascular drugs","author":"W Schoetensack","year":"1983","unstructured":"Schoetensack W, Bruckschen EG, Zech K. Urapidil. In: Scriabine A, ed.New drugs annual: cardiovascular drugs Vol. 1, New York: Raven Press, 1983:19\u201348."},{"issue":"Suppl D","key":"BF02026489_CR43","doi-asserted-by":"crossref","first-page":"1D","DOI":"10.1016\/0002-9149(89)90687-5","volume":"64","author":"PA Zwieten Van","year":"1989","unstructured":"Van Zwieten PA. Pharmacologic and therapeutic aspects of urapidil.Am J Cardiol 1989;64(Suppl D):1D-39D.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02026489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02026489\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02026489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T22:55:45Z","timestamp":1557788145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02026489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["BF02026489"],"URL":"https:\/\/doi.org\/10.1007\/bf02026489","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}